# Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma

> **NCT00367718** · PHASE2 · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Velcade

## Key facts

- **NCT ID:** NCT00367718
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left JHU and is not able to be reached for updates
- **Last updated:** 2020-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367718, "Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00367718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*